Susan Hasty, Publisher
Table of Contents . . . October 24th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Oncology Business Week | Other Publications
Amgen, Inc. - Aranesp approved for extended dosing by European Commission
Aphton Corporation - Therapeutic antibody deal signed to develop gastrointestinal cancer therapies
Australian Cancer Technology - Australian oncology firm lists on Frankfurt exchange
Cancer Screening - Preventive healthcare can overcome barriers of race, socioeconomic status
CancerVax Corporation - Enrollment completed in phase III trial of Canvaxin
Cerus Corporation - Efficacy and safety for cancer immunotherapy preclinical results published
Collaborations - Merck partnering with Nastech on nasal spray obesity drug
Curis, Inc. - Compound eradicates brain tumor in preclinical cancer model
Favrille, Inc. - Company initiates phase III clinical trial for FavId
Genentech, Inc. - Study of drug for advanced pancreatic cancer shows significant survival benefit
Genetronics Biomedical Corp. - Walter Singleton named vice president, clinical and regulatory affairs
Imaging Diagnostic Systems, Inc. - Agreement signed for exclusive sale of CT Laser Mammography System in China
Immunicon Corp. - Blood test provides window into treatment of metastatic cancer
Immunomedics, Inc. - Biopharmaceutical company's therapeutics candidates highlighted at conference
Medarex, Inc. - Combination trial to study MDX-010 with GVAX prostate cancer vaccine
Power3 Medical Products, Inc. - Research agreement signed to ID early biomarkers for breast cancer
Adherex Technologies, Inc. - Oncology company files registration statement with SEC
Alchemia Limited - Positive results reported for Alchemia anticancer compound
American Cancer Society - Survey finds one in three Connecticut adults experience pain on a daily basis
Baptist Medical Center - Diffuse malignant mesothelioma of the peritoneum and pleura studied
Baxa Corporation - Occupational safety institute published hazardous drug exposure report
Baylor College of Medicine, Houston - EBNA1-specific CD4+ T cells are key for control of Burkitt lymphoma
BioSphere Medical, Inc. - Device company appoints Martin Joyce as chief financial officer
Bispebjerg Hospital, Copenhagen - Study validates Sexual function-Vaginal changes Questionnaire
Cancer - Wellness/image booklet helps women undergoing, recovering from cancer therapy
Cancer Prevention - Actress urges adding cancer screening to women's healthcare
Cancer Treatment - Genetic test signals who will benefit from brain cancer drug
Charite University of Med Center Berlin - Pamidronate, zoledronate inhibit proliferation of human melanoma cells
Charles Nicolle Hosp., Rouen - IUD often a concomitant factor in tumoral syndrome due to bacterial infection
Chiba Cancer Center - Midkine promoter-driven gene therapy strikes down immortalized and tumor cells
Clavis Pharma AS - Anti-cancer drug CP-4055 shows promise of efficacy in phase I clinical study
Clinical Trials - Registry push could ease patients' hunt for drug
Complutense University, Madrid - Cannabinoids have several means for controlling glioma growth
Cytogen Corporation - Data demonstrates potential role for QUADRAMET in acute myeloid leukemia
DakoCytomation - Cancer diagnostics company launches automated staining instrument
Dartmouth Medical School - New arsenic drinking water standard may still be toxic
Erasmus Medical Center, in Rotterdam - Lycopene slows human prostate tumor growth in mice
Fourth Military Medical Univ., Shaanxi Province - Heat shock protein tumor vaccine enhances immune responses
Fourth Military Medical Univ., Xian - Nanoparticle-containing adriamycin increases distribution of the drug
Fox Chase Cancer Center - NHEJ DNA repair pathway has role in completion of HIV-1 DNA integration process
Fred Hutchinson Cancer Res. Ctr. - A glass of red wine a day may keep prostate cancer away
Gender-Based Medicine - Men, women more different than thought
Hadassah University Hospital - Transfected liver cancer cells offer a new venue for exploring hepatitis B
Hepatitis B - WHO stresses importance of childhood immunization against hepatitis B
Hormone Replacement Therapy - ACOG issues state-of-the-art guide to HRT
Hormone Replacement Therapy - Short-term impairment of gallbladder emptying associated with HRT
Human Genome Sciences, Inc. - HGS-ETR2 trials demonstrate safety, tolerability in advanced cancer patients
IDM - U.S. FDA authorizes start of phase 2 clinical trial on melanoma vaccine
IFR Jean Roche - VEGF signals the probability of breast cancer progression
ILEX Oncology, Inc. - FDA Oncologic Drugs Advisory Committee to review clofarabine
Indiana University - Interferon-gamma infusion prepares recipients for genetically modified cells
Inex Pharmaceuticals Corporation - Marqibo to be reviewed by FDA Oncologic Drugs Advisory Committee
Institute for Cancer Research & Treatment, Italy - Leukemia-derived dendritic cells become cells that stimulate T cells
Isis Pharmaceuticals - Antisense drug targeting STAT-3 demonstrates significant antitumor activity
Istanbul University - Turkish version of the CHBMS found adequately reliable, valid in Turkish women
Italian Soc. of Med. Radiology - MR is better than mammography for detecting additional disease in patients
Karolinska Institute - DNA vaccine elicits immune response in patients with prostate cancer
Kurume University, Fukuoka - Peptides eliciting multiple responses in lung cancer identified
Laval University - Dehydroepiandrosterone effect on heart disease risk is modest
Lilly - Alimta approved in the European Union for two cancer indications
London Research Institute - Cancer scientists make unexpected discovery on sperm development
Lorus Therapeutics Inc. - Virulizin study results published
Louisiana State University - Curing Helicobacter pylori infection does not prevent all gastric cancers
Lund University - Neural progenitor cell lines inhibit tumor growth
M.D. Anderson Cancer Center - Infliximab well tolerated/effective for steroid-resistant acute GVHD treatment
M.D. Anderson Cancer Center - Molecular switch found that allows cancer cells to become mobile
MEDTEC - Companies partner to distribute OneDose patient dosimetry system
MGI Pharma, Inc. - Kadian marketed in U.S. for cancer-associated pain
Matritech, Inc. - NMP66 breast cancer detection results presented at conference
Maxim Pharmaceuticals - Ceplene trial in advanced malignant melanoma fails to meet primary endpoint
National Cheng Kung University Medical College - The cytostatic effect of TNP-470 involves cyclin D1
National University of Singapore Hospital - Telomerase activity and COX-2 may be potential markers for certain cancers
Norwegian Cancer Society - Researchers report on professional collaboration with cancer patients, families
OSI Pharmaceuticals - Trials for tumor-blocking pancreatic cancer drug plus chemotherapy promising
Ovarian Cancer - Gene amplification is one mechanism for hK6 overexpression in ovarian cancer
Peregrine Pharmaceuticals, Inc. - Pharmaceutical company submits IND for novel anticancer agent Tarvacin
Pharmacyclics, Inc. - Pharma company releases data from phase 1 for nonHodgkin's B-cell lymphomas
PhotoCure - Swedish regulatory authorities to approve novel imaging drug Hexvix
PowderMed Ltd - Clinical trial initiated for novel therapeutic DNA cancer vaccine
Protherics PLC - Biopharma company names U.S. VP sales and marketing, provides business update
Proxima Therapeutics, Inc. - Medical device company received FDA clearance for MammoSite balloon catheter
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.